May 14, 2025

Gwen Nichols speaks with Saad Usmani on CAR-T therapy advances

Saad Usmani, MD, of Memorial Sloan Kettering Cancer Center in New York, and Gwen Nichols, MD, CMO of the Leukemia.

Myelodysplastic Syndromes

Study identifies nonmutational p53 dysfunction as MDS risk factor

Even in patients with myelodysplastic syndromes (MDS) who don’t have a mutation in tumor protein 53 (p53), the p53 protein.

Read More
Myelodysplastic Syndromes

FDA grants Orphan Drug designation for bexmarilimab in MDS

The US Food and Drug Administration (FDA) has granted Orphan Drug designation for bexmarilimab for the treatment of patients with.

Read More
Leukemia Acute Myeloid Leukemia

Triplet combination does not extend survival for patients with AML

A phase 1b/2 study found that the combination of azacitidine, venetoclax, and magrolimab was safe for the treatment of acute.

Read More

Top Categories

POPULAR NEWS

Meetings

MEMBERS

Editorial Board

Members Strong

Join Us Today and Become a Part of the SOHO Community

Benefits of membership include:

Career

SOHO Career Center

The Career Center provides SOHO members with the ability to find jobs in the field of Hematologic Oncology along with a variety of career advice. Select the 'Career Center' button to explore new job opportunities and career information.

The Career Center Allows SOHO Members to:

To access the SOHO Career Center click the following link.

Verified by MonsterInsights